Qure.ai vs SigTuple
In-depth comparison — valuation, funding, investors, founders & more
🇮🇳 India · Prashant Warier
Valuation
$270M
Total Funding
$157M
250 employees
🇮🇳 India · Rohit Kumar Pandey
Valuation
N/A
Total Funding
$20M
100-500 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Qure.ai and SigTuple compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Qure. SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists.
Qure.ai carries a known valuation of $270M, while SigTuple's valuation has not been publicly disclosed. On the funding side, Qure.ai has raised $157M in total — $137M more than SigTuple's $20M.
SigTuple has 1 year more market experience, having been founded in 2015 compared to Qure.ai's 2016 founding. In terms of growth stage, Qure.ai is at Series D while SigTuple is at Series B — a meaningful difference for investors evaluating risk and upside.
Both companies are headquartered in 🇮🇳 India, competing for the same regional talent and customer base. On Awaira's 0–100 composite score, Qure.ai leads with a score of 70, reflecting stronger overall fundamentals across valuation, funding, and growth signals.
Metrics Comparison
| Metric | Qure.ai | SigTuple |
|---|---|---|
💰Valuation | $270M | N/A |
📈Total Funding | $157MWINS | $20M |
📅Founded | 2016WINS | 2015 |
🚀Stage | Series D | Series B |
👥Employees | 250 | 100-500 |
🌍Country | India | India |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 70WINS | 60 |
Key Differences
Funding gap: Qure.ai has raised $137M more ($157M vs $20M)
Market experience: SigTuple has 1 year more (founded 2015 vs 2016)
Growth stage: Qure.ai is at Series D vs SigTuple at Series B
Team size: Qure.ai has 250 employees vs SigTuple's 100-500
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Qure.ai scores 70/100 vs SigTuple's 60/100
Which Should You Choose?
Use these signals to make the right call
Choose Qure.ai if…
Top Pick- ✓Higher Awaira Score — 70/100 vs 60/100
- ✓More established by valuation ($270M)
- ✓Stronger investor backing — raised $157M
- ✓Qure
Choose SigTuple if…
- ✓More market experience — founded in 2015
- ✓SigTuple develops AI-powered automated pathology solutions that digitize and analyze microscopy slides for blood, urine, sputum, and semen samples, enabling high-throughput diagnostic testing without the constant presence of trained pathologists
Funding History
Qure.ai raised $157M across 5 rounds. SigTuple raised $20M across 0 rounds.
Qure.ai
Series D
Jan 2021
Series C
Jan 2020
Series B
Jan 2018
Series A
Jan 2017
Lead: Accel Partners
Seed
Jan 2016
SigTuple
No public funding data available.
Investor Comparison
No shared investors detected between these two companies.
Unique to Qure.ai